Accurate Wealth Management’s Novavax NVAX Stock Holding History

Accurate Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-196	Closed	-$2.43K	–	1011
2022 Q4	$2.43K	Buy	+196	New	+$3.46K	﹤0.01%	1167

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Accurate Wealth Management's NVAX Position: Q1 2023 in Review

Accurate Wealth Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 196 shares — an estimated $2.43K sold.

Accurate Wealth Management first reported a position in NVAX in Q4 2022 and held it in 1 quarter. The position peaked at $2.43K in Q4 2022. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

Accurate Wealth Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
Accurate Wealth Management sold 196 Novavax shares in Q1 2023, an estimated $2.43K.
Accurate Wealth Management first reported a position in Novavax in Q4 2022 and held it in 1 quarter.
Accurate Wealth Management's Novavax position peaked at $2.43K in Q4 2022.
222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.